Global Valsartan Capsules Market Growth 2026-2032
The global Valsartan Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Valsartan capsules are a type of medication belonging to the class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which narrows blood vessels. By blocking this hormone, valsartan helps to relax blood vessels, lower blood pressure, and reduce the workload on the heart.
United States market for Valsartan Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Valsartan Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Valsartan Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Valsartan Capsules players cover Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Valsartan Capsules Industry Forecast” looks at past sales and reviews total world Valsartan Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Valsartan Capsules sales for 2026 through 2032. With Valsartan Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan Capsules industry.
This Insight Report provides a comprehensive analysis of the global Valsartan Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Valsartan Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Valsartan Capsules market?
What factors are driving Valsartan Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Valsartan Capsules market opportunities vary by end market size?
How does Valsartan Capsules break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Valsartan capsules are a type of medication belonging to the class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which narrows blood vessels. By blocking this hormone, valsartan helps to relax blood vessels, lower blood pressure, and reduce the workload on the heart.
United States market for Valsartan Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Valsartan Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Valsartan Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Valsartan Capsules players cover Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Valsartan Capsules Industry Forecast” looks at past sales and reviews total world Valsartan Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Valsartan Capsules sales for 2026 through 2032. With Valsartan Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan Capsules industry.
This Insight Report provides a comprehensive analysis of the global Valsartan Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Valsartan Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 40 Mg
- 80 Mg
- 160 Mg
- Others
- Treatment of Hypertension
- Treatment of Heart Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lepu Medical
- Novartis
- Mylan
- Teva Pharmaceutical Industries
- Torrent Pharmaceuticals
- Sun Pharmaceutical
- Dynemed
- Conquer
- Cisen Pharmaceutical
What is the 10-year outlook for the global Valsartan Capsules market?
What factors are driving Valsartan Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Valsartan Capsules market opportunities vary by end market size?
How does Valsartan Capsules break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Valsartan Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Valsartan Capsules by Country/Region, 2021, 2025 & 2032
2.2 Valsartan Capsules Segment by Type
2.2.1 40 Mg
2.2.2 80 Mg
2.2.3 160 Mg
2.2.4 Others
2.2.5 Valsartan Capsules Sales by Type
2.2.5.1 Global Valsartan Capsules Sales Market Share by Type (2021-2026)
2.2.5.2 Global Valsartan Capsules Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Valsartan Capsules Sale Price by Type (2021-2026)
2.3 Valsartan Capsules Segment by Application
2.3.1 Treatment of Hypertension
2.3.2 Treatment of Heart Disease
2.3.3 Others
2.3.4 Valsartan Capsules Sales by Application
2.3.4.1 Global Valsartan Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Valsartan Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Valsartan Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Valsartan Capsules Breakdown Data by Company
3.1.1 Global Valsartan Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Valsartan Capsules Sales Market Share by Company (2021-2026)
3.2 Global Valsartan Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Valsartan Capsules Revenue by Company (2021-2026)
3.2.2 Global Valsartan Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Valsartan Capsules Sale Price by Company
3.4 Key Manufacturers Valsartan Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Capsules Product Location Distribution
3.4.2 Players Valsartan Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VALSARTAN CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Valsartan Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Valsartan Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Valsartan Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Valsartan Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Valsartan Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Valsartan Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Valsartan Capsules Sales Growth
4.4 APAC Valsartan Capsules Sales Growth
4.5 Europe Valsartan Capsules Sales Growth
4.6 Middle East & Africa Valsartan Capsules Sales Growth
5 AMERICAS
5.1 Americas Valsartan Capsules Sales by Country
5.1.1 Americas Valsartan Capsules Sales by Country (2021-2026)
5.1.2 Americas Valsartan Capsules Revenue by Country (2021-2026)
5.2 Americas Valsartan Capsules Sales by Type (2021-2026)
5.3 Americas Valsartan Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valsartan Capsules Sales by Region
6.1.1 APAC Valsartan Capsules Sales by Region (2021-2026)
6.1.2 APAC Valsartan Capsules Revenue by Region (2021-2026)
6.2 APAC Valsartan Capsules Sales by Type (2021-2026)
6.3 APAC Valsartan Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valsartan Capsules by Country
7.1.1 Europe Valsartan Capsules Sales by Country (2021-2026)
7.1.2 Europe Valsartan Capsules Revenue by Country (2021-2026)
7.2 Europe Valsartan Capsules Sales by Type (2021-2026)
7.3 Europe Valsartan Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valsartan Capsules by Country
8.1.1 Middle East & Africa Valsartan Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Valsartan Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Valsartan Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Valsartan Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan Capsules
10.3 Manufacturing Process Analysis of Valsartan Capsules
10.4 Industry Chain Structure of Valsartan Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valsartan Capsules Distributors
11.3 Valsartan Capsules Customer
12 WORLD FORECAST REVIEW FOR VALSARTAN CAPSULES BY GEOGRAPHIC REGION
12.1 Global Valsartan Capsules Market Size Forecast by Region
12.1.1 Global Valsartan Capsules Forecast by Region (2027-2032)
12.1.2 Global Valsartan Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Valsartan Capsules Forecast by Type (2027-2032)
12.7 Global Valsartan Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lepu Medical
13.1.1 Lepu Medical Company Information
13.1.2 Lepu Medical Valsartan Capsules Product Portfolios and Specifications
13.1.3 Lepu Medical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lepu Medical Main Business Overview
13.1.5 Lepu Medical Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Valsartan Capsules Product Portfolios and Specifications
13.2.3 Novartis Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Valsartan Capsules Product Portfolios and Specifications
13.3.3 Mylan Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Teva Pharmaceutical Industries
13.4.1 Teva Pharmaceutical Industries Company Information
13.4.2 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceutical Industries Main Business Overview
13.4.5 Teva Pharmaceutical Industries Latest Developments
13.5 Torrent Pharmaceuticals
13.5.1 Torrent Pharmaceuticals Company Information
13.5.2 Torrent Pharmaceuticals Valsartan Capsules Product Portfolios and Specifications
13.5.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Torrent Pharmaceuticals Main Business Overview
13.5.5 Torrent Pharmaceuticals Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Dynemed
13.7.1 Dynemed Company Information
13.7.2 Dynemed Valsartan Capsules Product Portfolios and Specifications
13.7.3 Dynemed Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Dynemed Main Business Overview
13.7.5 Dynemed Latest Developments
13.8 Conquer
13.8.1 Conquer Company Information
13.8.2 Conquer Valsartan Capsules Product Portfolios and Specifications
13.8.3 Conquer Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Conquer Main Business Overview
13.8.5 Conquer Latest Developments
13.9 Cisen Pharmaceutical
13.9.1 Cisen Pharmaceutical Company Information
13.9.2 Cisen Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
13.9.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cisen Pharmaceutical Main Business Overview
13.9.5 Cisen Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Valsartan Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Valsartan Capsules by Country/Region, 2021, 2025 & 2032
2.2 Valsartan Capsules Segment by Type
2.2.1 40 Mg
2.2.2 80 Mg
2.2.3 160 Mg
2.2.4 Others
2.2.5 Valsartan Capsules Sales by Type
2.2.5.1 Global Valsartan Capsules Sales Market Share by Type (2021-2026)
2.2.5.2 Global Valsartan Capsules Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Valsartan Capsules Sale Price by Type (2021-2026)
2.3 Valsartan Capsules Segment by Application
2.3.1 Treatment of Hypertension
2.3.2 Treatment of Heart Disease
2.3.3 Others
2.3.4 Valsartan Capsules Sales by Application
2.3.4.1 Global Valsartan Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Valsartan Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Valsartan Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Valsartan Capsules Breakdown Data by Company
3.1.1 Global Valsartan Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Valsartan Capsules Sales Market Share by Company (2021-2026)
3.2 Global Valsartan Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Valsartan Capsules Revenue by Company (2021-2026)
3.2.2 Global Valsartan Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Valsartan Capsules Sale Price by Company
3.4 Key Manufacturers Valsartan Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Capsules Product Location Distribution
3.4.2 Players Valsartan Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VALSARTAN CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Valsartan Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Valsartan Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Valsartan Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Valsartan Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Valsartan Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Valsartan Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Valsartan Capsules Sales Growth
4.4 APAC Valsartan Capsules Sales Growth
4.5 Europe Valsartan Capsules Sales Growth
4.6 Middle East & Africa Valsartan Capsules Sales Growth
5 AMERICAS
5.1 Americas Valsartan Capsules Sales by Country
5.1.1 Americas Valsartan Capsules Sales by Country (2021-2026)
5.1.2 Americas Valsartan Capsules Revenue by Country (2021-2026)
5.2 Americas Valsartan Capsules Sales by Type (2021-2026)
5.3 Americas Valsartan Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valsartan Capsules Sales by Region
6.1.1 APAC Valsartan Capsules Sales by Region (2021-2026)
6.1.2 APAC Valsartan Capsules Revenue by Region (2021-2026)
6.2 APAC Valsartan Capsules Sales by Type (2021-2026)
6.3 APAC Valsartan Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valsartan Capsules by Country
7.1.1 Europe Valsartan Capsules Sales by Country (2021-2026)
7.1.2 Europe Valsartan Capsules Revenue by Country (2021-2026)
7.2 Europe Valsartan Capsules Sales by Type (2021-2026)
7.3 Europe Valsartan Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valsartan Capsules by Country
8.1.1 Middle East & Africa Valsartan Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Valsartan Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Valsartan Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Valsartan Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan Capsules
10.3 Manufacturing Process Analysis of Valsartan Capsules
10.4 Industry Chain Structure of Valsartan Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valsartan Capsules Distributors
11.3 Valsartan Capsules Customer
12 WORLD FORECAST REVIEW FOR VALSARTAN CAPSULES BY GEOGRAPHIC REGION
12.1 Global Valsartan Capsules Market Size Forecast by Region
12.1.1 Global Valsartan Capsules Forecast by Region (2027-2032)
12.1.2 Global Valsartan Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Valsartan Capsules Forecast by Type (2027-2032)
12.7 Global Valsartan Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lepu Medical
13.1.1 Lepu Medical Company Information
13.1.2 Lepu Medical Valsartan Capsules Product Portfolios and Specifications
13.1.3 Lepu Medical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lepu Medical Main Business Overview
13.1.5 Lepu Medical Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Valsartan Capsules Product Portfolios and Specifications
13.2.3 Novartis Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Valsartan Capsules Product Portfolios and Specifications
13.3.3 Mylan Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Teva Pharmaceutical Industries
13.4.1 Teva Pharmaceutical Industries Company Information
13.4.2 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceutical Industries Main Business Overview
13.4.5 Teva Pharmaceutical Industries Latest Developments
13.5 Torrent Pharmaceuticals
13.5.1 Torrent Pharmaceuticals Company Information
13.5.2 Torrent Pharmaceuticals Valsartan Capsules Product Portfolios and Specifications
13.5.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Torrent Pharmaceuticals Main Business Overview
13.5.5 Torrent Pharmaceuticals Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Dynemed
13.7.1 Dynemed Company Information
13.7.2 Dynemed Valsartan Capsules Product Portfolios and Specifications
13.7.3 Dynemed Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Dynemed Main Business Overview
13.7.5 Dynemed Latest Developments
13.8 Conquer
13.8.1 Conquer Company Information
13.8.2 Conquer Valsartan Capsules Product Portfolios and Specifications
13.8.3 Conquer Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Conquer Main Business Overview
13.8.5 Conquer Latest Developments
13.9 Cisen Pharmaceutical
13.9.1 Cisen Pharmaceutical Company Information
13.9.2 Cisen Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
13.9.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cisen Pharmaceutical Main Business Overview
13.9.5 Cisen Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Valsartan Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Valsartan Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40 Mg
Table 4. Major Players of 80 Mg
Table 5. Major Players of 160 Mg
Table 6. Major Players of Others
Table 7. Global Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 8. Global Valsartan Capsules Sales Market Share by Type (2021-2026)
Table 9. Global Valsartan Capsules Revenue by Type (2021-2026) & ($ million)
Table 10. Global Valsartan Capsules Revenue Market Share by Type (2021-2026)
Table 11. Global Valsartan Capsules Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Global Valsartan Capsules Sale by Application (2021-2026) & (K Dose)
Table 13. Global Valsartan Capsules Sale Market Share by Application (2021-2026)
Table 14. Global Valsartan Capsules Revenue by Application (2021-2026) & ($ million)
Table 15. Global Valsartan Capsules Revenue Market Share by Application (2021-2026)
Table 16. Global Valsartan Capsules Sale Price by Application (2021-2026) & (US$/Dose)
Table 17. Global Valsartan Capsules Sales by Company (2021-2026) & (K Dose)
Table 18. Global Valsartan Capsules Sales Market Share by Company (2021-2026)
Table 19. Global Valsartan Capsules Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Valsartan Capsules Revenue Market Share by Company (2021-2026)
Table 21. Global Valsartan Capsules Sale Price by Company (2021-2026) & (US$/Dose)
Table 22. Key Manufacturers Valsartan Capsules Producing Area Distribution and Sales Area
Table 23. Players Valsartan Capsules Products Offered
Table 24. Valsartan Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Valsartan Capsules Sales by Geographic Region (2021-2026) & (K Dose)
Table 28. Global Valsartan Capsules Sales Market Share Geographic Region (2021-2026)
Table 29. Global Valsartan Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Valsartan Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Valsartan Capsules Sales by Country/Region (2021-2026) & (K Dose)
Table 32. Global Valsartan Capsules Sales Market Share by Country/Region (2021-2026)
Table 33. Global Valsartan Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Valsartan Capsules Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Valsartan Capsules Sales by Country (2021-2026) & (K Dose)
Table 36. Americas Valsartan Capsules Sales Market Share by Country (2021-2026)
Table 37. Americas Valsartan Capsules Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 39. Americas Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 40. APAC Valsartan Capsules Sales by Region (2021-2026) & (K Dose)
Table 41. APAC Valsartan Capsules Sales Market Share by Region (2021-2026)
Table 42. APAC Valsartan Capsules Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 44. APAC Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 45. Europe Valsartan Capsules Sales by Country (2021-2026) & (K Dose)
Table 46. Europe Valsartan Capsules Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 48. Europe Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 49. Middle East & Africa Valsartan Capsules Sales by Country (2021-2026) & (K Dose)
Table 50. Middle East & Africa Valsartan Capsules Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 52. Middle East & Africa Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 53. Key Market Drivers & Growth Opportunities of Valsartan Capsules
Table 54. Key Market Challenges & Risks of Valsartan Capsules
Table 55. Key Industry Trends of Valsartan Capsules
Table 56. Valsartan Capsules Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Valsartan Capsules Distributors List
Table 59. Valsartan Capsules Customer List
Table 60. Global Valsartan Capsules Sales Forecast by Region (2027-2032) & (K Dose)
Table 61. Global Valsartan Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Dose)
Table 63. Americas Valsartan Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Valsartan Capsules Sales Forecast by Region (2027-2032) & (K Dose)
Table 65. APAC Valsartan Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Europe Valsartan Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Dose)
Table 69. Middle East & Africa Valsartan Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Valsartan Capsules Sales Forecast by Type (2027-2032) & (K Dose)
Table 71. Global Valsartan Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Valsartan Capsules Sales Forecast by Application (2027-2032) & (K Dose)
Table 73. Global Valsartan Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Lepu Medical Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 75. Lepu Medical Valsartan Capsules Product Portfolios and Specifications
Table 76. Lepu Medical Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 77. Lepu Medical Main Business
Table 78. Lepu Medical Latest Developments
Table 79. Novartis Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Valsartan Capsules Product Portfolios and Specifications
Table 81. Novartis Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Mylan Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Valsartan Capsules Product Portfolios and Specifications
Table 86. Mylan Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Teva Pharmaceutical Industries Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceutical Industries Valsartan Capsules Product Portfolios and Specifications
Table 91. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 92. Teva Pharmaceutical Industries Main Business
Table 93. Teva Pharmaceutical Industries Latest Developments
Table 94. Torrent Pharmaceuticals Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 95. Torrent Pharmaceuticals Valsartan Capsules Product Portfolios and Specifications
Table 96. Torrent Pharmaceuticals Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 97. Torrent Pharmaceuticals Main Business
Table 98. Torrent Pharmaceuticals Latest Developments
Table 99. Sun Pharmaceutical Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 100. Sun Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
Table 101. Sun Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 102. Sun Pharmaceutical Main Business
Table 103. Sun Pharmaceutical Latest Developments
Table 104. Dynemed Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 105. Dynemed Valsartan Capsules Product Portfolios and Specifications
Table 106. Dynemed Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 107. Dynemed Main Business
Table 108. Dynemed Latest Developments
Table 109. Conquer Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 110. Conquer Valsartan Capsules Product Portfolios and Specifications
Table 111. Conquer Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 112. Conquer Main Business
Table 113. Conquer Latest Developments
Table 114. Cisen Pharmaceutical Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 115. Cisen Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
Table 116. Cisen Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 117. Cisen Pharmaceutical Main Business
Table 118. Cisen Pharmaceutical Latest Developments
Table 1. Valsartan Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Valsartan Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40 Mg
Table 4. Major Players of 80 Mg
Table 5. Major Players of 160 Mg
Table 6. Major Players of Others
Table 7. Global Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 8. Global Valsartan Capsules Sales Market Share by Type (2021-2026)
Table 9. Global Valsartan Capsules Revenue by Type (2021-2026) & ($ million)
Table 10. Global Valsartan Capsules Revenue Market Share by Type (2021-2026)
Table 11. Global Valsartan Capsules Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Global Valsartan Capsules Sale by Application (2021-2026) & (K Dose)
Table 13. Global Valsartan Capsules Sale Market Share by Application (2021-2026)
Table 14. Global Valsartan Capsules Revenue by Application (2021-2026) & ($ million)
Table 15. Global Valsartan Capsules Revenue Market Share by Application (2021-2026)
Table 16. Global Valsartan Capsules Sale Price by Application (2021-2026) & (US$/Dose)
Table 17. Global Valsartan Capsules Sales by Company (2021-2026) & (K Dose)
Table 18. Global Valsartan Capsules Sales Market Share by Company (2021-2026)
Table 19. Global Valsartan Capsules Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Valsartan Capsules Revenue Market Share by Company (2021-2026)
Table 21. Global Valsartan Capsules Sale Price by Company (2021-2026) & (US$/Dose)
Table 22. Key Manufacturers Valsartan Capsules Producing Area Distribution and Sales Area
Table 23. Players Valsartan Capsules Products Offered
Table 24. Valsartan Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Valsartan Capsules Sales by Geographic Region (2021-2026) & (K Dose)
Table 28. Global Valsartan Capsules Sales Market Share Geographic Region (2021-2026)
Table 29. Global Valsartan Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Valsartan Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Valsartan Capsules Sales by Country/Region (2021-2026) & (K Dose)
Table 32. Global Valsartan Capsules Sales Market Share by Country/Region (2021-2026)
Table 33. Global Valsartan Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Valsartan Capsules Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Valsartan Capsules Sales by Country (2021-2026) & (K Dose)
Table 36. Americas Valsartan Capsules Sales Market Share by Country (2021-2026)
Table 37. Americas Valsartan Capsules Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 39. Americas Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 40. APAC Valsartan Capsules Sales by Region (2021-2026) & (K Dose)
Table 41. APAC Valsartan Capsules Sales Market Share by Region (2021-2026)
Table 42. APAC Valsartan Capsules Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 44. APAC Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 45. Europe Valsartan Capsules Sales by Country (2021-2026) & (K Dose)
Table 46. Europe Valsartan Capsules Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 48. Europe Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 49. Middle East & Africa Valsartan Capsules Sales by Country (2021-2026) & (K Dose)
Table 50. Middle East & Africa Valsartan Capsules Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Valsartan Capsules Sales by Type (2021-2026) & (K Dose)
Table 52. Middle East & Africa Valsartan Capsules Sales by Application (2021-2026) & (K Dose)
Table 53. Key Market Drivers & Growth Opportunities of Valsartan Capsules
Table 54. Key Market Challenges & Risks of Valsartan Capsules
Table 55. Key Industry Trends of Valsartan Capsules
Table 56. Valsartan Capsules Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Valsartan Capsules Distributors List
Table 59. Valsartan Capsules Customer List
Table 60. Global Valsartan Capsules Sales Forecast by Region (2027-2032) & (K Dose)
Table 61. Global Valsartan Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Dose)
Table 63. Americas Valsartan Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Valsartan Capsules Sales Forecast by Region (2027-2032) & (K Dose)
Table 65. APAC Valsartan Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Europe Valsartan Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Valsartan Capsules Sales Forecast by Country (2027-2032) & (K Dose)
Table 69. Middle East & Africa Valsartan Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Valsartan Capsules Sales Forecast by Type (2027-2032) & (K Dose)
Table 71. Global Valsartan Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Valsartan Capsules Sales Forecast by Application (2027-2032) & (K Dose)
Table 73. Global Valsartan Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Lepu Medical Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 75. Lepu Medical Valsartan Capsules Product Portfolios and Specifications
Table 76. Lepu Medical Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 77. Lepu Medical Main Business
Table 78. Lepu Medical Latest Developments
Table 79. Novartis Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Valsartan Capsules Product Portfolios and Specifications
Table 81. Novartis Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Mylan Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Valsartan Capsules Product Portfolios and Specifications
Table 86. Mylan Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Teva Pharmaceutical Industries Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceutical Industries Valsartan Capsules Product Portfolios and Specifications
Table 91. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 92. Teva Pharmaceutical Industries Main Business
Table 93. Teva Pharmaceutical Industries Latest Developments
Table 94. Torrent Pharmaceuticals Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 95. Torrent Pharmaceuticals Valsartan Capsules Product Portfolios and Specifications
Table 96. Torrent Pharmaceuticals Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 97. Torrent Pharmaceuticals Main Business
Table 98. Torrent Pharmaceuticals Latest Developments
Table 99. Sun Pharmaceutical Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 100. Sun Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
Table 101. Sun Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 102. Sun Pharmaceutical Main Business
Table 103. Sun Pharmaceutical Latest Developments
Table 104. Dynemed Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 105. Dynemed Valsartan Capsules Product Portfolios and Specifications
Table 106. Dynemed Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 107. Dynemed Main Business
Table 108. Dynemed Latest Developments
Table 109. Conquer Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 110. Conquer Valsartan Capsules Product Portfolios and Specifications
Table 111. Conquer Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 112. Conquer Main Business
Table 113. Conquer Latest Developments
Table 114. Cisen Pharmaceutical Basic Information, Valsartan Capsules Manufacturing Base, Sales Area and Its Competitors
Table 115. Cisen Pharmaceutical Valsartan Capsules Product Portfolios and Specifications
Table 116. Cisen Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 117. Cisen Pharmaceutical Main Business
Table 118. Cisen Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Valsartan Capsules
Figure 2. Valsartan Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Capsules Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Valsartan Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Valsartan Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Valsartan Capsules Sales Market Share by Country/Region (2025)
Figure 10. Valsartan Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40 Mg
Figure 12. Product Picture of 80 Mg
Figure 13. Product Picture of 160 Mg
Figure 14. Product Picture of Others
Figure 15. Global Valsartan Capsules Sales Market Share by Type in 2026
Figure 16. Global Valsartan Capsules Revenue Market Share by Type (2021-2026)
Figure 17. Valsartan Capsules Consumed in Treatment of Hypertension
Figure 18. Global Valsartan Capsules Market: Treatment of Hypertension (2021-2026) & (K Dose)
Figure 19. Valsartan Capsules Consumed in Treatment of Heart Disease
Figure 20. Global Valsartan Capsules Market: Treatment of Heart Disease (2021-2026) & (K Dose)
Figure 21. Valsartan Capsules Consumed in Others
Figure 22. Global Valsartan Capsules Market: Others (2021-2026) & (K Dose)
Figure 23. Global Valsartan Capsules Sale Market Share by Application (2025)
Figure 24. Global Valsartan Capsules Revenue Market Share by Application in 2026
Figure 25. Valsartan Capsules Sales by Company in 2026 (K Dose)
Figure 26. Global Valsartan Capsules Sales Market Share by Company in 2026
Figure 27. Valsartan Capsules Revenue by Company in 2026 ($ millions)
Figure 28. Global Valsartan Capsules Revenue Market Share by Company in 2026
Figure 29. Global Valsartan Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Valsartan Capsules Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 32. Americas Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 33. APAC Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 34. APAC Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 35. Europe Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 36. Europe Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 38. Middle East & Africa Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 39. Americas Valsartan Capsules Sales Market Share by Country in 2026
Figure 40. Americas Valsartan Capsules Revenue Market Share by Country (2021-2026)
Figure 41. Americas Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 42. Americas Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 43. United States Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Valsartan Capsules Sales Market Share by Region in 2026
Figure 48. APAC Valsartan Capsules Revenue Market Share by Region (2021-2026)
Figure 49. APAC Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 50. APAC Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 51. China Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. India Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Valsartan Capsules Sales Market Share by Country in 2026
Figure 59. Europe Valsartan Capsules Revenue Market Share by Country (2021-2026)
Figure 60. Europe Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 61. Europe Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 62. Germany Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. France Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Valsartan Capsules Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 70. Egypt Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Valsartan Capsules in 2026
Figure 76. Manufacturing Process Analysis of Valsartan Capsules
Figure 77. Industry Chain Structure of Valsartan Capsules
Figure 78. Channels of Distribution
Figure 79. Global Valsartan Capsules Sales Market Forecast by Region (2027-2032)
Figure 80. Global Valsartan Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Valsartan Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Valsartan Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Valsartan Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Valsartan Capsules Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Valsartan Capsules
Figure 2. Valsartan Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Capsules Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Valsartan Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Valsartan Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Valsartan Capsules Sales Market Share by Country/Region (2025)
Figure 10. Valsartan Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40 Mg
Figure 12. Product Picture of 80 Mg
Figure 13. Product Picture of 160 Mg
Figure 14. Product Picture of Others
Figure 15. Global Valsartan Capsules Sales Market Share by Type in 2026
Figure 16. Global Valsartan Capsules Revenue Market Share by Type (2021-2026)
Figure 17. Valsartan Capsules Consumed in Treatment of Hypertension
Figure 18. Global Valsartan Capsules Market: Treatment of Hypertension (2021-2026) & (K Dose)
Figure 19. Valsartan Capsules Consumed in Treatment of Heart Disease
Figure 20. Global Valsartan Capsules Market: Treatment of Heart Disease (2021-2026) & (K Dose)
Figure 21. Valsartan Capsules Consumed in Others
Figure 22. Global Valsartan Capsules Market: Others (2021-2026) & (K Dose)
Figure 23. Global Valsartan Capsules Sale Market Share by Application (2025)
Figure 24. Global Valsartan Capsules Revenue Market Share by Application in 2026
Figure 25. Valsartan Capsules Sales by Company in 2026 (K Dose)
Figure 26. Global Valsartan Capsules Sales Market Share by Company in 2026
Figure 27. Valsartan Capsules Revenue by Company in 2026 ($ millions)
Figure 28. Global Valsartan Capsules Revenue Market Share by Company in 2026
Figure 29. Global Valsartan Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Valsartan Capsules Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 32. Americas Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 33. APAC Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 34. APAC Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 35. Europe Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 36. Europe Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Valsartan Capsules Sales 2021-2026 (K Dose)
Figure 38. Middle East & Africa Valsartan Capsules Revenue 2021-2026 ($ millions)
Figure 39. Americas Valsartan Capsules Sales Market Share by Country in 2026
Figure 40. Americas Valsartan Capsules Revenue Market Share by Country (2021-2026)
Figure 41. Americas Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 42. Americas Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 43. United States Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Valsartan Capsules Sales Market Share by Region in 2026
Figure 48. APAC Valsartan Capsules Revenue Market Share by Region (2021-2026)
Figure 49. APAC Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 50. APAC Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 51. China Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. India Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Valsartan Capsules Sales Market Share by Country in 2026
Figure 59. Europe Valsartan Capsules Revenue Market Share by Country (2021-2026)
Figure 60. Europe Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 61. Europe Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 62. Germany Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. France Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Valsartan Capsules Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Valsartan Capsules Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Valsartan Capsules Sales Market Share by Application (2021-2026)
Figure 70. Egypt Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Valsartan Capsules Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Valsartan Capsules in 2026
Figure 76. Manufacturing Process Analysis of Valsartan Capsules
Figure 77. Industry Chain Structure of Valsartan Capsules
Figure 78. Channels of Distribution
Figure 79. Global Valsartan Capsules Sales Market Forecast by Region (2027-2032)
Figure 80. Global Valsartan Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Valsartan Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Valsartan Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Valsartan Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Valsartan Capsules Revenue Market Share Forecast by Application (2027-2032)
